Why GLP-1 Storage and Monitoring Matter GLP-1 drugs are fragile biologics that must be stored in a validated +2 C to +8 C range to maintain full potency
[8] Comprehensive meta-analyses examining data from randomised controlled trials have found no statistically significant increase in thyroid cancer cases among GLP-1 users
Venlafaxine extended-release formulations are designed to release medication gradually, so the gastric emptying delay from tirzepatide is unlikely to meaningfully change its absorption profile
Although all of the trials were randomized, some with small cohorts failed to fully balance baseline characteristics between experimental and control groups despite the randomization [27, 28]
In SURMOUNT-1, published in NEJM in 2022, tirzepatide at the 15 mg weekly dose produced a mean placebo-adjusted body weight reduction of 17.8% at 72 weeks in adults with obesity (Jastreboff et al., NEJM, 2022)
An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1ras) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is)
